The hallmark of atopic asthma is transient airways hyperresponsiveness (AHR) preceded by aeroallergen-induced Th-cell activation. This is preceded by upregulation of CD86 on resident airway dendritic cells (DCs) that normally lack competence in T-cell triggering. Moreover, AHR duration is controlled via T-regulatory (Treg) cells, which can attenuate CD86 upregulation on DC. We show that airway mucosal Treg/DC interaction represents an accessible therapeutic target for asthma control. Notably, baseline airway Treg activity in sensitized rats can be boosted by microbe-derived stimulation of the gut, resulting in enhanced capacity to control CD86 expression on airway DC triggered by aeroallergen and accelerated resolution of AHR. © 2011 Society for Mucosal Immunology.
CITATION STYLE
Strickland, D. H., Judd, S., Thomas, J. A., Larcombe, A. N., Sly, P. D., & Holt, P. G. (2011). Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma control. Mucosal Immunology, 4(1), 43–52. https://doi.org/10.1038/mi.2010.43
Mendeley helps you to discover research relevant for your work.